BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 28 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $253 | +3514.3% | 39,521 | +3685.5% | 0.00% | – |
Q1 2023 | $7 | -94.4% | 1,044 | -96.4% | 0.00% | – |
Q4 2022 | $126 | -99.9% | 28,896 | +66.8% | 0.00% | – |
Q3 2022 | $97,000 | -62.7% | 17,320 | -32.6% | 0.00% | – |
Q1 2022 | $260,000 | +1081.8% | 25,696 | +862.8% | 0.00% | – |
Q4 2021 | $22,000 | – | 2,669 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmond Asset Management, LLC | 131,731 | $508,000 | 0.16% |
SABBY MANAGEMENT, LLC | 160,182 | $618,000 | 0.12% |
ZEKE CAPITAL ADVISORS, LLC | 45,000 | $174,000 | 0.01% |
Freedom Investment Management, Inc. | 16,339 | $63,000 | 0.01% |
Virtu Financial LLC | 15,121 | $58,000 | 0.00% |
TORONTO DOMINION BANK | 12 | $0 | 0.00% |
ROYAL BANK OF CANADA | 17 | $0 | 0.00% |
UBS Group AG | 632 | $2,000 | 0.00% |
OSAIC HOLDINGS, INC. | 6,012 | $23,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |